ACE2 and COVID-19: Further, an atypical pattern of the RAS in COVID-19 patients was noted with a decreased ACE/ACE2 ratio and increased renin, angiotensin, kininogen, bradykinin and bradykinin receptors, which altogether induced hypotension, vasodilation, etc. and most of the symptoms related to patients with COVID-19 [24].